{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-022185","form_type":"8-K","ticker":"RGBP","cik":"0001589150","company_name":"Regen BioPharma Inc","filed_at":"2025-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.840621+00:00","generated_at":"2026-05-16T20:22:19.669715+00:00","sec_items":[],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"medium","headline":"Regen BioPharma issues 23.68M common shares for cash and debt conversion in Oct-Nov 2025","bullets":["Oct 8, 2025: issued 6.8M shares for $68,000 cash.","Oct 27, 2025: issued 3.5M shares for $35,000 cash, and 4.5M shares to satisfy $30,204 debt principal plus $13,536 accrued interest.","Oct 28, 2025: issued 7.1M shares for $71,000 cash.","Nov 10, 2025: issued 1.78M shares for $17,800 cash under Tier 2 Reg A offering.","All shares sold directly by management with no underwriter or commission."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-022185","json":"https://secwatch.observer/filing/0001493152-25-022185.json","markdown":"https://secwatch.observer/filing/0001493152-25-022185.md","text":"https://secwatch.observer/filing/0001493152-25-022185.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1589150/000149315225022185/0001493152-25-022185-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1589150/000149315225022185/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T20:22:19.669715+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}